3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hematologic Diseases
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
65
Nivolumab
56
Ipilimumab
34
Specimen Handling
23
Magnetic Resonance Spectroscopy
21
Cyclophosphamide
17
Biopsy
13
Radiosurgery
12
relatlimab
11
fludarabine
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine phosphate
8
dabrafenib
8
lifileucel
7
encorafenib
7
aldesleukin
7
atezolizumab
6
Interleukin-2
6
cemiplimab
5
X-Rays
5
Paclitaxel
5
Immunoglobulin G
5
Blood Specimen Collection
5
Taxes
4
Radiotherapy
4
Pemetrexed
4
Gemcitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
cedazuridine
×
90 days
×
Clear all
No trials found.